Altitude People Series, Week 3 — Business: The Billionaire Who Built a Psychedelics Company on One Mushroom Trip
Week 3 of the Altitude People Series covers business leaders who have talked about their own psychedelic use. At the center is Christian Angermayer, whose one mushroom trip led to atai, an early stake in Compass and a $2.8 billion sale to Eli Lilly. Plus Steve Jobs, Sam Altman, GoDaddy's Bob Parsons, Tim Ferriss, Bryan Johnson and, in a reported account, Sergey Brin.
Altitude People Series, Week 2 — Politicians: The Lawmakers Who Tried Ibogaine, and Why
Kyrsten Sinema and Morgan Luttrell are the two sitting or former members of Congress who've gone on record about personally trying ibogaine — not as recreational use, but as a specific response to a family history of dementia and a traumatic brain injury, respectively. Here's what they said, to whom, and the policy fights they're now leading because of it.
Altitude People Series, Week 1 — Sports: The Athletes Who Went Public About Psychedelics, and Why
From Aaron Rodgers' ayahuasca retreat in Costa Rica to the small, loosely connected network of former NFL players using ibogaine to treat what they believe is CTE, here's the documented record of athletes who've spoken publicly about psychedelics — on the record, with named journalists, and linked to the compound coverage behind each story.
Bicycle Day, Explained: The Three Days in 1943 That Accidentally Invented LSD
Every April 19th, psychedelic communities mark "Bicycle Day" — the anniversary of Albert Hofmann's first intentional LSD trip. But the story most people repeat is the one Hofmann told 36 years later in his memoir. The report he actually filed three days after it happened tells a rougher, less poetic version.
The "Nibble It" Problem: What Your Doctor Doesn't Have to Tell You About Off-Label Prescriptions
About half of all US prescriptions are written off-label — for a use, population, or dose the drug was never formally studied for. There's no FDA requirement that your doctor tell you that. We looked at three of the most commonly off-label-prescribed psychiatric drugs and what the side-effect data actually shows at the doses people are actually taking.
Nausea for 12 Hours vs. Sexual Dysfunction for Years: The Side-Effect Math Nobody's Doing on Mental Health Drugs
A single dose of a psychedelic causes nausea and headache that resolve within a day. A daily SSRI or Wellbutrin can cause sexual dysfunction in up to half of patients for as long as they're on it — and one of the biggest names in the daily-pill business has a $757 million fraud settlement to show for how it got there.
Kambo: The Ceremony That Promises Purification and Delivers Peril
A critical look at the frog secretion ritual gaining traction in wellness circles — including the first suspected UK death linked to it — and the medical evidence that should give you serious pause.
What Is Evidence-Based Healing? A Guide to Altitude Global's Standards
The healing and wellness space is experiencing a credibility crisis. Here's how Altitude evaluates practitioners.